China rural healthcare pilot planned
This article was originally published in Clinica
China is to pilot a rural healthcare programme across eight provinces, with a view to closing the gap between rural and urban health, and in access to healthcare. The five-year programme (the starting date has not been announced) will cost around US$60m and will specifically address the health of women, children and the elderly; there is also likely to be an emphasis on AIDS, TB, hepatitis and schistosomiasis (a snail-borne parasitic disease present in fresh water). US$50m will be loaned by the World Bank and nearly $10m from the UK government’s department for international development. The loan will be repaid by China’s ministry of finance (80%) and provincial finance departments (20%). The provinces to be piloted include: Shanxi, Qinghai, Heilongjiang, Gansu, Jiangsu, Henan and Chongqing, according to Chinese news agency Xinhua.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.